Health – Dominican Today

ONPECO backs nutritional labeling policy

Santo Domingo.- The National Observatory for Consumer Protection (ONPECO) has voiced strong support for a Ministry of Public Health resolution that promotes the implementation of Front-of-Pack Nutritional Warning Labels (EFAN) in the Dominican Republic.

Santo Domingo.- The National Observatory for Consumer Protection (ONPECO) has voiced strong support for a Ministry of Public Health resolution that promotes the implementation of Front-of-Pack Nutritional Warning Labels (EFAN) in the Dominican Republic. According to ONPECO, this measure is essential to uphold citizens’ right to know what they are consuming and to make informed choices that may reduce the risk of non-communicable diseases.

The organization stressed that EFAN does not require companies to change product formulas, but simply aims to provide clear information so consumers can decide for themselves. ONPECO criticized the resistance to the initiative, noting that it mirrors successful policies in other Latin American countries like Mexico, Chile, and Argentina, where no economic or employment impacts have been recorded.

Citing a study by the Healthy America Coalition (CLAS), ONPECO addressed and dismissed myths promoted by some industries—such as claims that WHO/PAHO nutrient standards are too strict or that EFAN harms the economy. It reaffirmed that the WHO guidelines are science-based and that transparent labeling aligns with global standards like ISO 26000 on corporate responsibility and the OECD’s calls for clear food information.

Finally, ONPECO urged broad dissemination of the resolution, reiterating that the Dominican State is constitutionally obligated to protect public health and ensure consumers’ right to accurate product information.

3 months 1 week ago

Health

Health Archives - Barbados Today

Lack of early autism screening a major concern, says association head

The lack of early autism screening in Barbados remains a major concern, according to the President of the Barbados Autism Association, Frank Johnson, who hopes that public events like the Autism Heroes Walk will help raise awareness and drive change.

“The main challenge is getting screening for the children early enough. A child should really be screened at three years old. It’s a little difficult screening before three, but if a child has missed developmental milestones . . . you really should become aware that there may be a challenge involved,” Johnson said on Monday, as over 200 men, women, and children took part in the annual Autism Heroes Fun and Wellness Walk and Cool Down Fair.

Beyond early diagnosis, Johnson pointed to other issues, including the absence of reliable national data on autism.

“We don’t have strict numbers here in Barbados,” he explained. “There has not been what I call a census taken of the exact number of children with this disability.

“The last national census that was done… it didn’t focus on a particular developmental challenge, which I think it should do.”

He also highlighted a critical shortage of trained professionals, saying: “We do need more specialists. We need more occupational therapists, and speech therapists or speech and pathology specialists. They do a fantastic job, but they are oversubscribed.”

However, for many families, the cost of private screening and therapy remains a heavy burden.

“A lot of our parents have to pay privately for consultants to carry out screening and testing . . . . Getting it done privately is expensive . . . but as I say to parents out there: think of it as an investment in your child’s future.

“A lot of young parents . . . have no idea what they’re up against . . . except that they know there is something wrong. They go to their GP or the polyclinic and report that their child is missing the developmental milestones.”

To address these challenges, Johnson said the association is working on forming partnerships that would make screening more affordable.

“In the near future, possibly working with insurance companies to provide support grants to parents who cannot afford the intervention. If we can swing that towards those groups in the next couple of years, we will be making fantastic strides.”

In addition to those efforts, the association is preparing to expand its physical presence. A new headquarters in the Garrison area is currently being renovated, which Johnson hopes will become a hub for affordable, accessible support and therapy.

“We are just about to finish our renovated building, which has been granted to us by the government,” he said. “We’ve taken out a lease for ten years, with a renewable ten years, just around the corner from the Barbados Council for the Disabled.

“We hope to go into partnership with speech therapists and occupational therapists to be able to offer subsidised programmes. We do see ourselves as providing many different answers . . . for all income brackets.”

He added that the association is launching new initiatives to support those families emotionally and mentally. (LG)

 

The post Lack of early autism screening a major concern, says association head appeared first on Barbados Today.

3 months 1 week ago

Health, Local News

PAHO/WHO | Pan American Health Organization

Disease elimination takes center stage at Vaccination Week in the Americas launch

Disease elimination takes center stage at Vaccination Week in the Americas launch

Cristina Mitchell

28 Apr 2025

Disease elimination takes center stage at Vaccination Week in the Americas launch

Cristina Mitchell

28 Apr 2025

3 months 1 week ago

Medical News, Health News Latest, Medical News Today - Medical Dialogues |

Low-Dose Sirolimus as Effective as High-Dose for Kaposiform Hemangioendothelioma Treatment, suggests study

Researchers have found in new research that low-dose sirolimus is noninferior to high-dose sirolimus in the treatment of Kaposiform Hemangioendothelioma (KHE), suggesting that lower doses may be a viable treatment option.

It remains unknown whether low-dose sirolimus can replace high-dose sirolimus for the treatment of kaposiform hemangioendothelioma (KHE) without the Kasabach–Merritt phenomenon (KMP). A study was done to evaluate the noninferiority and safety of low-dose versus high-dose sirolimus in Kaposiform Hemangioendothelioma patients.

This randomized, multicenter, open-label, noninferiority trial was conducted from February 2021 to August 2022. Participants received either a low-dose sirolimus regimen (blood trough concentration 5-8 ng/mL) or a high-dose sirolimus regimen (blood trough concentration 10-15 ng/mL). The primary endpoint was the difference in the proportion of patients between groups who achieved an objective response, defined as a ≥20% reduction in Kaposiform Hemangioendothelioma volume at month 12.

Results: In this study, 39 were in the low-dose group, and 40 were in the high-dose group. At 1 year of treatment, 90.0% in the high-dose group and 89.7% in the low-dose group achieved an objective response (difference, 0.3%; 95% confidence interval -13.1 to 13.6). The incidences of total adverse events (AEs) and serious adverse events were similar between the two groups, but respiratory, skin and mucosal adverse events were less common in the low-dose group.

Low-dose sirolimus is noninferior to high-dose sirolimus in treating Kaposiform Hemangioendothelioma.

Reference:

Efficacy and Safety of High- vs Low-Dose Sirolimus in Patients with Kaposiform Hemangioendothelioma: A Randomized Clinical Trial Zhou, Jiangyuan et al. Journal of the American Academy of Dermatology, Volume 0, Issue 0

3 months 1 week ago

Dermatology,Dermatology News,Top Medical News

Health | NOW Grenada

PM on first official visit to Bolivarian Republic of Venezuela

“During the official visit, Prime Minister Mitchell is scheduled to hold high-level discussions with President Nicolas Maduro Moros to discuss key areas of interest”

3 months 1 week ago

Agriculture/Fisheries, Business, Health, Politics, PRESS RELEASE, Travel/Tourism, andy williams, bolivarian republic of venezuela, dickon mitchell, joseph andall, venezuela. nicolas maduro moros

KFF Health News

When Hospitals Ditch Medicare Advantage Plans, Thousands of Members Get To Leave, Too

For several years, Fred Neary had been seeing five doctors at the Baylor Scott & White Health system, whose 52 hospitals serve central and northern Texas, including Neary’s home in Dallas. But in October, his Humana Medicare Advantage plan — an alternative to government-run Medicare — warned that Baylor and the insurer were fighting over a new contract.

If they couldn’t reach an agreement, he’d have to find new doctors or new health insurance.

“All my medical information is with Baylor Scott & White,” said Neary, 87, who retired from a career in financial services. His doctors are a five-minute drive from his house. “After so many years, starting over with that many new doctor relationships didn’t feel like an option.”

After several anxious weeks, Neary learned Humana and Baylor were parting ways as of this year, and he was forced to choose between the two. Because the breakup happened during the annual fall enrollment period for Medicare Advantage, he was able to pick a new Advantage plan with coverage starting Jan. 1, a day after his Humana plan ended.

Other Advantage members who lose providers are not as lucky. Although disputes between health systems and insurers happen all the time, members are usually locked into their plans for the year and restricted to a network of providers, even if that network shrinks. Unless members qualify for what’s called a special enrollment period, switching plans or returning to traditional Medicare is allowed only at year’s end, with new coverage starting in January.

But in the past 15 months, the Centers for Medicare & Medicaid Services, which oversees the Medicare Advantage program, has quietly offered roughly three-month special enrollment periods allowing thousands of Advantage members in at least 13 states to change plans. They were also allowed to leave Advantage plans entirely and choose traditional Medicare coverage without penalty, regardless of when they lost their providers. But even when CMS lets Advantage members leave a plan that lost a key provider, insurers can still enroll new members without telling them the network has shrunk.

At least 41 hospital systems have dropped out of 62 Advantage plans serving all or parts of 25 states since July, according to Becker’s Hospital Review. Over the past two years, separations between Advantage plans and health systems have tripled, said FTI Consulting, which tracks reports of the disputes.

CMS spokesperson Catherine Howden said it is “a routine occurrence” for the agency to determine that provider network changes trigger a special enrollment period for their members. “It has happened many times in the past, though we have seen an uptick in recent years.”

Still, CMS would not identify plans whose members were allowed to disenroll after losing health providers. The agency also would not say whether the plans violated federal provider network rules intended to ensure that Medicare Advantage members have sufficient providers within certain distances and travel times.

The secrecy around when and how Advantage members can escape plans after their doctors and hospitals drop out worries Sen. Ron Wyden of Oregon, the senior Democrat on the Senate Finance Committee, which oversees CMS.

“Seniors enrolled in Medicare Advantage plans deserve to know they can change their plan when their local doctor or hospital exits the plan due to profit-driven business practices,” Wyden said.

The increase in insurer-provider breakups isn’t surprising, given the growing popularity of Medicare Advantage. The plans attracted about 54% of the 61.2 million people who had both Medicare Parts A and B and were eligible to sign up for Medicare Advantage in 2024, according to KFF, a health information nonprofit that includes KFF Health News.

The plans can offer supplemental benefits unavailable from traditional Medicare because the federal government pays insurers about 20% more per member than traditional Medicare per-member costs, according to the Medicare Payment Advisory Commission, which advises Congress. The extra spending, which some lawmakers call wasteful, will total about $84 billion in 2025, MedPAC estimates. While traditional Medicare does not offer the additional benefits Advantage plans advertise, it does not limit beneficiaries’ choice of providers. They can go to any doctor or hospital that accepts Medicare, as nearly all do.

Sanford Health, the largest rural health system in the U.S., serving parts of seven states from South Dakota to Michigan, decided to leave a Humana Medicare Advantage plan last year that covered 15,000 of its patients. “It’s not so much about the finances or administrative burden, although those are real concerns,” said Nick Olson, Sanford Health’s chief financial officer. “The most important thing for us is the fact that coverage denials and prior authorization delays impact the care a patient receives, and that’s unacceptable.”

The National Association of Insurance Commissioners, representing insurance regulators from every state, Puerto Rico, and the District of Columbia, has appealed to CMS to help Advantage members.

“State regulators in several states are seeing hospitals and crucial provider groups making decisions to no longer contract with any MA plans, which can leave enrollees without ready access to care,” the group wrote in September. “Lack of CMS guidance could result in unnecessary financial or medical injury to America’s seniors.”

The commissioners appealed again last month to Health and Human Services Secretary Robert F. Kennedy Jr. “Significant network changes trigger important rights for beneficiaries, and they should receive clear notice of their rights and have access to counseling to help them make appropriate choices,” they wrote.

The insurance commissioners asked CMS to consider offering a special enrollment period for all Advantage members who lose the same major provider, instead of placing the burden on individuals to find help on their own. No matter what time of year, members would be able to change plans or enroll in government-run Medicare.

Advantage members granted this special enrollment period who choose traditional Medicare get a bonus: If they want to purchase a Medigap policy — supplemental insurance that helps cover Medicare’s considerable out-of-pocket costs — insurers can’t turn them away or charge them more because of preexisting health conditions.

Those potential extra costs have long been a deterrent for people who want to leave Medicare Advantage for traditional Medicare.

“People are being trapped in Medicare Advantage because they can’t get a Medigap plan,” said Bonnie Burns, a training and policy specialist at California Health Advocates, a nonprofit watchdog that helps seniors navigate Medicare.

Guaranteed access to Medigap coverage is especially important when providers drop out of all Advantage plans. Only four states — Connecticut, Massachusetts, Maine, and New York — offer that guarantee to anyone who wants to reenroll in Medicare.

But some hospital systems, including Great Plains Health in North Platte, Nebraska, are so frustrated by Advantage plans that they won’t participate in any of them.

It had the same problems with delays and denials of coverage as other providers, but one incident stands out for CEO Ivan Mitchell: A patient too sick to go home had to stay in the hospital an extra six weeks because her plan wouldn’t cover care in a rehabilitation facility.

With traditional Medicare the only option this year for Great Plains Health patients, Nebraska insurance commissioner Eric Dunning asked for a special enrollment period with guaranteed Medigap access for some 1,200 beneficiaries. After six months, CMS agreed.

Once Delaware’s insurance commissioner contacted CMS about the Bayhealth medical system dropping out of a Cigna Advantage plan, members received a special enrollment period starting in January.

Maine’s congressional delegation pushed for an enrollment period for nearly 4,000 patients of Northern Light Health after the 10-hospital system dropped out of a Humana Advantage plan last year.

“Our constituents have told us that they are anticipating serious challenges, ranging from worries about substantial changes to cost-sharing rates to concerns about maintaining care with current providers,” the delegation told CMS.

CMS granted the request to ensure “that MA enrollees have access to medically necessary care,” then-CMS Administrator Chiquita Brooks-LaSure wrote to Sen. Angus King (I-Maine).

Minnesota insurance officials appealed to CMS on behalf of some 75,000 members of Aetna, Humana, and UnitedHealthcare Advantage plans after six health systems announced last year they would leave the plans in 2025. So many provider changes caused “tremendous problems,” said Kelli Jo Greiner, director of the Minnesota State Health Insurance Assistance Program, known as a SHIP, at the Minnesota Board on Aging. SHIP counselors across the country provide Medicare beneficiaries free help choosing and using Medicare drug and Advantage plans.

Providers serving about 15,000 of Minnesota’s Advantage members ultimately agreed to stay in the insurers’ networks. CMS decided 14,000 Humana members qualified for a network-change special enrollment period.

The remaining 46,000 people — Aetna and UnitedHealthcare Advantage members — who lost access to four health systems were not eligible for the special enrollment period. CMS decided their plans still had enough other providers to care for them.

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.

USE OUR CONTENT

This story can be republished for free (details).

3 months 1 week ago

Aging, Health Care Costs, Health Industry, Insurance, Medicare, Rural Health, CMS, Connecticut, Delaware, Hospitals, Maine, Massachusetts, Medicare Advantage, Michigan, Minnesota, Nebraska, New York, South Dakota, texas

KFF Health News

Cuando los abuelos ya no te reconocen

Ocurrió hace más de una década, pero el momento permanece en su memoria.

Sara Stewart conversaba con su madre, Barbara Cole, entonces de 86 años, en el comedor de su casa de Bar Harbor, en Maine. Stewart, abogada tenía en ese momento 59 años y estaba haciendo una de sus largas visitas desde fuera del estado.

Ocurrió hace más de una década, pero el momento permanece en su memoria.

Sara Stewart conversaba con su madre, Barbara Cole, entonces de 86 años, en el comedor de su casa de Bar Harbor, en Maine. Stewart, abogada tenía en ese momento 59 años y estaba haciendo una de sus largas visitas desde fuera del estado.

Dos o tres años antes, Cole había comenzado a mostrar signos preocupantes de demencia, probablemente debido a una serie de pequeños derrames cerebrales. “No quería sacarla de su casa”, contó Stewart.

Así que, con un batallón de ayudantes —una empleada doméstica, visitas familiares frecuentes, un vecino atento y un servicio de entrega de comidas—, Cole pudo quedarse en la casa que ella y su difunto esposo habían construido 30 años atrás.

Se las arreglaba bien y solía parecer alegre y conversadora. Pero esta conversación en 2014 tuvo un dramático giro. “Me dijo: ‘¿De dónde nos conocemos? ¿de la escuela?’”, recordó su hija y primogénita. “Sentí como si me hubieran pateado”.

Stewart recuerda haber pensado: “En el curso natural de las cosas, se suponía que morirías antes que yo. Pero nunca se suponía que olvidaras quién soy”. Más tarde, sola, lloró.

Las personas con demencia avanzada suelen no reconocer a sus seres queridos, a sus parejas, hijos y hermanos. Para cuando Stewart y su hermano menor trasladaron a Cole a un centro de atención para la memoria un año después, la mujer ya había perdido casi por completo la capacidad de recordar sus nombres o vínculos.

“Es bastante común en las últimas etapas” de la enfermedad, dijo Alison Lynn, directora de trabajo social del Penn Memory Center, quien ha dirigido grupos de apoyo para cuidadores de personas con demencia por una década.

Ha escuchado muchas versiones de este relato, un momento descrito con dolor, ira, frustración, alivio o una combinación de estos sentimientos.

Estos cuidadores “ven muchas pérdidas, revierten hitos, y este es uno de esos momentos, un cambio fundamental” en una relación cercana, dijo. “Puede llevar a las personas a una crisis existencial”.

Es difícil determinar qué saben o sienten las personas con demencia —una categoría que incluye la enfermedad de Alzheimer y otros trastornos cognitivos—. “No tenemos forma de preguntarle a la persona ni de ver una resonancia magnética”, señaló Lynn. “Todo es pura deducción”.

Pero los investigadores están comenzando a investigar cómo reaccionan los familiares cuando un ser querido ya parece no reconocerlos. Un estudio cualitativo publicado recientemente en la revista Dementia analizó entrevistas en profundidad con hijos adultos que cuidaban de madres con demencia que, al menos en una ocasión, no los habían reconocido.

“Es muy desestabilizador”, dijo Kristie Wood, psicóloga clínica investigadora del Campus Médico Anschutz de la Universidad de Colorado y coautora del estudio. “El reconocimiento reafirma la identidad, y cuando desaparece, las personas sienten que han perdido parte de sí mismas”.

Aunque comprendían que no implicaba un rechazo sino un síntoma de la enfermedad de sus madres, algunos hijos adultos se culpaban a sí mismos, agregó.

“Se cuestionaban su papel. ‘¿Acaso no era lo suficientemente importante como para que me recuerde?'”, dijo Wood. Esto puede hacer que se alejen o que sus visitas se vuelvan menos frecuentes.

Pauline Boss, la terapeuta familiar que desarrolló hace décadas la teoría de la “pérdida ambigua”, señala que puede implicar ausencia física, como cuando un soldado desaparece en combate, o ausencia psicológica, incluyendo la falta de reconocimiento debido a la demencia.

La sociedad no tiene forma de reconocer la transición cuando “una persona está físicamente presente pero psicológicamente ausente”, dijo Boss. “No hay certificado de defunción, ni ritual donde amigos y vecinos vengan a sentarse contigo y te consuelen”.

“La gente se siente culpable si llora a alguien que aún está vivo”, continuó. “Pero si bien no es lo mismo que una muerte confirmada, es una pérdida real, que ocurre una y otra vez”.

La falta de reconocimiento adopta diferentes formas. Algunos familiares informan que, aunque un ser querido con demencia ya no puede recordar su nombre ni su parentesco exacto, todavía parecen felices de verlo.

“En un sentido narrativo, ya no sabe quién soy, que yo era su hija Janet”, contó Janet Keller, de 69 años, actriz de Port Townsend, Washington, hablando de su difunta madre, diagnosticada con Alzheimer en un correo electrónico. “Pero siempre supo que yo era alguien a quien apreciaba y con quien quería reír y a quien le agarraba la mano”.

A los cuidadores les reconforta seguir sintiendo una conexión. Sin embargo, una de las participantes en el estudio sobre demencia informó que ahora sentía a su madre como una extrañas, y que la relación ya no le proporcionaba ninguna recompensa emocional.

“Era como si estuviera visitando al cartero”, le dijo al entrevistador.

Larry Levine, de 67 años, administrador de atención médica jubilado de Rockville, Maryland, observó cómo la capacidad de su esposo para reconocerlo cambiaba de forma impredecible.

Levine y Arthur Windreich, pareja desde hacía 43 años, se habían casado en 2010, cuando Washington, DC, legalizó el matrimonio entre personas del mismo sexo. Al año siguiente, Windreich tuvo un diagnóstico de Alzheimer de inicio temprano.

Levine se convirtió en su cuidador hasta su fallecimiento a los 70 años, a finales de 2023.

“Su condición era zigzagueante”, dijo Levine. Windreich se había mudado a una unidad de cuidados de la memoria. “Un día, me llamaba ‘el hombre amable que viene de visita'”, dijo Levine. “Al día siguiente, me llamaba por mi nombre”.

Incluso en sus últimos años, cuando, como muchos pacientes con demencia, Windreich se volvió prácticamente silencioso, “había cierto reconocimiento”, dijo su esposo. “A veces se le veía en los ojos, ese brillo en lugar de la expresión vacía que solía tener”.

Sin embargo otras veces “no había ningún afecto”. Levine a menudo salía del centro llorando.

Buscó la ayuda de su terapeuta y sus hermanas, y recientemente se unió a un grupo de apoyo para cuidadores LGBTQ+ de personas con demencia, a pesar que su esposo ya había fallecido.

Los grupos de apoyo, en persona o por internet, “son medicina para el cuidador”, dijo Boss. “Es importante no aislarse”.

Lynn anima a los participantes de sus grupos a que también encuentren rituales personales para conmemorar la pérdida de reconocimiento y otros hitos que marcan un antes y un después. “Quizás enciendan una vela. Quizás recen una oración”, dijo.

Alguien que se sienta en shivá, parte del ritual de duelo judío, podría reunir a un pequeño grupo de amigos o familiares para recordar y compartir historias, aunque el ser querido con demencia no haya fallecido.

“Que alguien más participe puede ser muy reconfortante”, dijo Lynn. “Dice: ‘Veo el dolor que estás sintiendo'”.

De vez en cuando, la niebla de la demencia parece disiparse brevemente.

Investigadores de Penn y de otros centros han señalado un fenómeno sorprendente llamado “lucidez paradójica”. Alguien con demencia grave, luego de meses o años sin comunicarse, recupera repentinamente la lucidez y puede inventar un nombre, decir algunas palabras apropiadas, contar un chiste, hacer contacto visual o cantar con la radio.

Aunque comunes, estos episodios suelen durar solo unos segundos y no significan un cambio real en el deterioro de la persona. Los esfuerzos por recrear las experiencias tienden a fracasar.

“Es un instante”, dijo Lynn. Pero los cuidadores suelen reaccionar con sorpresa y alegría; algunos interpretan el episodio como evidencia de que, a pesar de la profundización de la demencia, no se les olvida del todo.

Stewart experimentó un pequeño incidente como esos unos meses antes de la muerte de su madre. Estaba en el apartamento de su madre cuando una enfermera le pidió que la acompañara al final del pasillo.

“Al salir de la habitación, mi madre me llamó por mi nombre”, dijo. Aunque Cole solía parecer contenta de verla, “no había usado mi nombre desde que tengo memoria”.

No volvió a ocurrir, pero eso no importó. “Fue maravilloso”, dijo Stewart.

La serie de columnas The New Old Age se producen a través de una alianza con The New York Times.

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.

USE OUR CONTENT

This story can be republished for free (details).

3 months 1 week ago

Aging, Mental Health, Noticias En Español, Dementia, Latinos, Maine, Maryland, Washington

STAT

Opinion: Therapy and poetry have more in common than you think

Who’s on the couch here? The psychiatrist or the poet? The poem or the practice of psychiatry?

As a poet and a psychiatrist/therapist, I exist in both practices, and the worlds of each enrich the other. Each speaks with abandon, and each interrogates the other, and there are many ways in which each discipline supports the other, some obvious, some not so obvious.

Who’s on the couch here? The psychiatrist or the poet? The poem or the practice of psychiatry?

As a poet and a psychiatrist/therapist, I exist in both practices, and the worlds of each enrich the other. Each speaks with abandon, and each interrogates the other, and there are many ways in which each discipline supports the other, some obvious, some not so obvious.

Read the rest…

3 months 1 week ago

First Opinion, Mental Health

Health – Demerara Waves Online News- Guyana

Region Nine gets high marks for HPV vaccination says health minister at Project HealthBridge launch

Almost all eligible persons in Region Nine (Upper Takatu-Upper Essequibo) have taken the vaccine that protects against the human papillomavirus (HPV), which can cause cervical cancer, Minister of Health Dr Frank Anthony said Sunday. “I was just in Region Nine a day ago (Saturday) and I was talking to the people there and I was ...

Almost all eligible persons in Region Nine (Upper Takatu-Upper Essequibo) have taken the vaccine that protects against the human papillomavirus (HPV), which can cause cervical cancer, Minister of Health Dr Frank Anthony said Sunday. “I was just in Region Nine a day ago (Saturday) and I was talking to the people there and I was ...

3 months 1 week ago

Health, News, cervical cancer, HPV vaccination, launch, Project HealthBridge, Rotaract Club of the University of Guyana (RCUG)

Health – Demerara Waves Online News- Guyana

More US forensic pathologists expected for Adriana Younge’s postmortem

Two forensic pathologists from the United States (US) are due in Guyana to conduct the autopsy on the body of 11-year-old Adriana Younge, which was found in a pool at Double Day Hotel, Tuschen, East Bank Essequibo. The Ministry of Health has added Dr Glenn A. Rudner, a forensic and anatomic pathologist affiliated with Mount ...

Two forensic pathologists from the United States (US) are due in Guyana to conduct the autopsy on the body of 11-year-old Adriana Younge, which was found in a pool at Double Day Hotel, Tuschen, East Bank Essequibo. The Ministry of Health has added Dr Glenn A. Rudner, a forensic and anatomic pathologist affiliated with Mount ...

3 months 1 week ago

Crime, Health, News, Politics, Adriana Younge, autopsy, forensic pathologists, Gary L Collins, Glenn A Rudner, postmortem, Shubhakar Karra Paul, transparency

PAHO/WHO | Pan American Health Organization

PAHO urges expanded access to malaria diagnosis and treatment to accelerate elimination in the Americas

PAHO urges expanded access to malaria diagnosis and treatment to accelerate elimination in the Americas

Cristina Mitchell

25 Apr 2025

PAHO urges expanded access to malaria diagnosis and treatment to accelerate elimination in the Americas

Cristina Mitchell

25 Apr 2025

3 months 1 week ago

PAHO/WHO | Pan American Health Organization

El Salvador strengthens health care in the framework of the Alliance for Primary Health Care in the Americas

El Salvador strengthens health care in the framework of the Alliance for Primary Health Care in the Americas

Cristina Mitchell

25 Apr 2025

El Salvador strengthens health care in the framework of the Alliance for Primary Health Care in the Americas

Cristina Mitchell

25 Apr 2025

3 months 1 week ago

The Medical News

Patients with asthma reminded of the increased risk of severe asthma attacks from overusing blue inhalers

This reminder follows updates to product information and the National Institute for Health and Care Excellence (NICE) guidance for short-acting beta 2 agonists (SABAs), including salbutamol and terbutaline, which are used to relieve sudden asthma symptoms such as chest tightness, wheezing, coughing and breathlessness.

This reminder follows updates to product information and the National Institute for Health and Care Excellence (NICE) guidance for short-acting beta 2 agonists (SABAs), including salbutamol and terbutaline, which are used to relieve sudden asthma symptoms such as chest tightness, wheezing, coughing and breathlessness.

3 months 2 weeks ago

Medical News, Health News Latest, Medical News Today - Medical Dialogues |

Abbvie seeks USFDA nod for trenibotulinumtoxinE for glabellar lines treatment

North Chicago, Ill.: AbbVie has announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for trenibotulinumtoxinE (TrenibotE) for the treatment of moderate to severe glabellar lines.

North Chicago, Ill.: AbbVie has announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for trenibotulinumtoxinE (TrenibotE) for the treatment of moderate to severe glabellar lines.

"The submission provides evidence of TrenibotE's differentiated clinical profile to offer patients an opportunity to experience a faster onset and shorter treatment duration as an introduction to a neurotoxin," said Darin Messina, Ph.D., senior vice president, aesthetics R&D, AbbVie. "TrenibotE has the potential to transform the aesthetic toxin treatment landscape for new patients interested in the facial aesthetics category."

"New patients wanting to experience the aesthetic benefits of a neurotoxin cite "fear of looking unnatural" as a barrier to initiating neurotoxin use for aesthetic indications. If approved, TrenibotE will be the first serotype E neurotoxin offering patients the opportunity to experience a neurotoxin with rapid clinical effect for a shorter duration of time as a trial before getting treatment with BOTOX Cosmetic," the Cmpany stated in a recent releae.

The BLA submission is supported by data from over 2,100 patients treated with TrenibotE in the clinical program, which included two pivotal Phase 3 clinical studies evaluating TrenibotE for the treatment of moderate to severe glabellar lines (M21-500 and M21-508) and a Phase 3 open-label safety study (M21-509). All primary and secondary endpoints of the Phase 3 studies were met, with a rapid onset of action as early as 8 hours after drug administration (the earliest assessment time) and observed efficacy duration for 2-3 weeks. Treatment-emergent adverse events for TrenibotE were similar to placebo, both as a single treatment and up to three consecutive treatments. Topline data from the Phase 3 pivotal studies were previously shared.

"Concern about an unnatural outcome remains a significant barrier for many patients considering medical aesthetics treatment," said Cheryl Burgess, MD, FAAD, lead clinical investigator for one of the Phase 3 studies. "Treatment with a product offering rapid onset of effect and short duration of action could help address this barrier and empower confidence for patients exploring their aesthetics treatment journey with innovation from the makers of BOTOX Cosmetic."

3 months 2 weeks ago

News,Industry,Pharma News,Latest Industry News

Pages